Reported Oct 2, 2023 · Announced
Hospira, Inc. recalls Hospira 4.2% Sodium Bicarbonate Injection, USP, 1% Lidocaine HCl Injection, USP, and 2% Lidocaine HCl Injection, USP due to Potential…
Hospira, Inc.
Risk not classifiedThe agency has not ranked the risk yet — treat the notice as a caution.What you should do
Stop using the product and follow the return or refund instructions in the firm's announcement.
Is this the product you have?
4.2% Sodium Bicarbonate InjectionUSP1% Lidocaine HCl InjectionUSPand 2% Lidocaine HCl Injection
- USP BrandHospira. Drugs
Why it was recalled
Potential Presence of Glass Particulates
The agency has not ranked the risk yet — treat the notice as a caution.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Hospira, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.